ALVO
- Alvotech
()
Overview
Company Summary
Alvotech is a biopharmaceutical company that focuses on the development and manufacturing of high-quality biosimilar medicines. Biosimilars are essentially biologic drugs that are highly similar to existing reference biologics, which are complex, large-molecule drugs derived from living organisms.
Alvotech's main objective is to provide effective and affordable treatments to patients by leveraging its expertise in biosimilar development and production. They aim to address the increasing demand for cost-effective alternatives to reference biologics, particularly in areas such as rheumatology, gastroenterology, and oncology.
The company follows a rigorous development process, including extensive scientific and clinical research, to demonstrate that their biosimilars are comparable in terms of safety, efficacy, and quality to the reference biologics. This process involves in-depth analytical testing and large-scale manufacturing to ensure consistent and reliable production.
By developing biosimilars, Alvotech aims to increase patient access to essential medicines, improve overall health outcomes, and contribute to the sustainability of healthcare systems around the world. Their emphasis on delivering quality, affordable treatments places them at the forefront of the biosimilar market.